Premium
Dinotefuran/pyriproxyfen/permethrin pemphigus‐like drug reaction in three dogs
Author(s) -
Bizikova Petra,
Moriello Karen A.,
Linder Keith E.,
Sauber Leslie
Publication year - 2015
Publication title -
veterinary dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.744
H-Index - 60
eISSN - 1365-3164
pISSN - 0959-4493
DOI - 10.1111/vde.12202
Subject(s) - permethrin , medicine , dermatology , adverse effect , pemphigus foliaceus , drug , flea , pathology , immunology , pharmacology , autoantibody , pesticide , biology , veterinary medicine , antibody , agronomy
Background Pemphigus foliaceus ( PF ) can occur spontaneously or as a reaction pattern associated with cutaneous adverse drug reactions. Hypothesis/Objectives To provide clinical, histological and immunological assessments of three dogs that developed cutaneous adverse drug reactions following application of a topical flea and tick control product, which contained dinotefuran, pyriproxyfen and permethrin. Animals Three client‐owned dogs. Results The dogs exhibited rapid onset of papules, pustules and crusts at the site of application of the flea control product. In two dogs, the lesions became generalized, while the third exhibited a localized phenotype. Both dogs with generalized lesions required immunosuppressive treatment; one achieved remission after 1 year of treatment and one was euthanized due to adverse effects of glucocorticoids. The dog with a localized phenotype was treated with topical glucocorticoids exclusively and achieved remission after 10 months. Histology revealed subcorneal pustular dermatitis, with acantholysis of keratinocytes and focal to multifocal full‐thickness epidermal necrosis. These features are similar to those previously reported for pesticide‐triggered and spontaneous PF . Tissue‐bound IgG was detected in two of three dogs, and autoantibodies targeting canine desmocollin‐1 were identified in the serum of the one dog from which a sample was available. Conclusions and clinical importance Cutaneous adverse drug reaction caused by a flea control product containing dinotefuran, pyriproxyfen and permethrin closely resembled those reported for other pesticide‐associated PF ‐like cutaneous adverse drug reactions. Although it appears to be a rare entity, clinicians and pathologists should be aware of the potential for flea and tick control products to trigger PF ‐like reactions.